<DOC>
	<DOCNO>NCT01959035</DOCNO>
	<brief_summary>To obtain information safety , tolerability effectiveness aripiprazole once-monthly manner consistent intend use everyday clinical practice patient schizophrenia complete Study 14724A / NCT01795547 .</brief_summary>
	<brief_title>Aripiprazole Once-monthly Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients recruit among complete treatment aripiprazole Study 14724A / NCT01795547 . The patient judge potentially benefit 24week treatment aripiprazole oncemonthly accord clinical opinion investigator . The patient agree protocoldefined use effective contraception . The patient diagnose primary psychiatric disorder schizophrenia Study 14724A / NCT01795547 . The patient clinically significant unstable illness diagnose Study 14724A / NCT01795547 . The patient significant risk harm himself/herself others accord investigator 's judgement accord ColumbiaSuicide Severity Rating Scale ( CSSRS ) . The patient disease take medication could , investigator 's opinion , interfere assessment safety , tolerability efficacy , interfere conduct interpretation study . The patient one clinical laboratory test value outside reference range , base blood urine sample take conduct Study 14724A / NCT01795547 , investigator 's opinion , potential risk patient 's safety . The patient , investigator 's opinion , unlikely comply protocol unsuitable reason . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>